Status:
UNKNOWN
the Effect of Misoprostol on Intra-operative Blood Loss During Myomectomy Operation
Lead Sponsor:
ahmed nagy shaker ramadan
Conditions:
Myoma;Uterus
Blood Loss
Eligibility:
FEMALE
25-50 years
Phase:
PHASE3
Brief Summary
assess the effect of using misoprostol in abdominal myomectomy operations on blood loss, duration of the operation and possible operative complications. Research question Does pre-operative misoprosto...
Detailed Description
. Type of Study : Prospective double blind randomized placebo controlled clinical trial. * Study Setting : This study will be conducted in Ain Shams University Maternity hospital. * Study Period : 6 ...
Eligibility Criteria
Inclusion
- Premenopausal patients aged between 35 to 50 years old.
- Five or less symptomatic uterine myomas .
- Maximum diameter of the largest myoma is 6 cm .
- All myomas are subserous or intramural.
- Uterine size less than 24 weeks pregnancy
Exclusion
- History of previous surgery.
- Allergy to Misoprostol.
- Hypertension.
- Cardiac and Pulmonary diseases.
- Patients who have bleeding disorders.
- Anemia (Hb \< 10g %).
- Chronic endocrine or metabolic diseases such as Diabetes.
- Obesity (body mass index \> 30 kg/m2).
- Cases that will require intraoperative conversion of myomectomy to hysterectomy.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03483142
Start Date
November 1 2017
End Date
July 30 2018
Last Update
May 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams Maternity Hospital
Cairo, Abbasia, Egypt, 11566